Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer
Status:
Terminated
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the clinical trial is to assess the clinical benefit as measured by time to
tumor progression of Abraxane plus hormonal therapy when applied to previously untreated
patients with unresectable or metastatic adenocarcinoma of the prostate, as well as to assess
safety and tolerability of the study drug regimen and to evaluate secondary efficacy
endpoints such as overall survival and duration of response.
Phase:
Phase 2
Details
Lead Sponsor:
The Methodist Hospital Research Institute The Methodist Hospital System